Specialised Therapeutics today announced that the Thailand Food and Drug Administration approved YONDELIS® (trabectedin) on 24 July 2026 for the treatment of adult patients with advanced soft tissue sarcoma (STS).
+65 3158 9940
1300 798 820
+64 9801 0299